Selenium supplementation decreases nuclear factor‐kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Objective The role of selenium in preventing cardiovascular diseases has been largely described. Oxidative stress and the subsequent activation of nuclear factor‐kappa B (NF‐κB) have been linked to the development of vascular complications. We investigated the effects of selenium supplementation in type 2 diabetic patients on several oxidative stress parameters and NF‐κB activity. Methods We enrolled 56 type 2 diabetic patients with similar glycaemic control: 21 were supplemented by selenium (960 µg d−1, 3 months) and 27 received a placebo, and 10 nondiabetic subjects formed the control group. To determine NF‐κB activation, we used an electrophoretic mobility shift assay followed by a semi‐quantitative determination of NF‐κB in peripheral blood mononuclear cells. Results Selenium treatment resulted in a significant increase in plasma selenium and red‐cell Se GSH px activity. It had no effect on lipid peroxidation measured by malone‐dialdehyde (MDA) or on red‐cell Cu/Zn SOD. NF‐κB activity was increased by 80% in diabetic patients. In patients receiving selenium supplementation, selenium NF‐κB activity was significantly reduced, reaching the same level as the nondiabetic control group. Conclusion In type 2 diabetic patients, activation of NF‐κB measured in peripheral blood monocytes can be reduced by selenium supplementation, confirming its importance in the prevention of cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2003) · Diabetes · doi:10.2337/diabetes.52.1.1 · Cited by 1,482
NF-κB: pivotal mediator or innocent bystander in atherogenesis?
Collins, T., & Cybulsky, M. I. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10373 · Cited by 727
Cited by
Selenium in human health and disease
Fairweather-Tait, S. J., Bao, Y., Broadley, M. R., Collings, R., Ford, D., Hesketh, J. E., & Hurst, R. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3275 · Cited by 1,330
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007176.pub2 · Cited by 924
Selenium in food and the human body: A review
Navarro-Alarcon, M., & Cabrera-Vique, C. (2008) · Science of The Total Environment · doi:10.1016/j.scitotenv.2008.06.024 · Cited by 870
Stranges, S., Marshall, J. R., Natarajan, R., Donahue, R. P., Trevisan, M., Combs, G. F., Cappuccio, F. P., Ceriello, A., & Reid, M. E. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-4-200708210-00175 · Cited by 712
Contribution of Selected Vitamins and Trace Elements to Immune Function
Wintergerst, E. S., Maggini, S., & Hornig, D. H. (2007) · Annals of Nutrition and Metabolism · doi:10.1159/000107673 · Cited by 692
“Selenium supplementation (960 μg/day for 3 months) was shown to decrease NF-κB activity in peripheral blood mononuclear cells from type-2 diabetic patients. Since oxidative stress and the subsequent activation of NF-κB have been linked to the development of vascular complications and NF-κB has been identified in ather…”
Background
Metadata
- Authors
- Faure, P., Ramon, O., Favier, A., & Halimi, S.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2004-07
- Volume
- 34
- Issue
- 7
- Pages
- 475-481
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W2050962873
- Cited by
- 81
- References
- 3
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.